Vetter looks ahead to further expansions to meet supply chain demand
Ongoing investments in the supply chain
for complex injectable medications
- Committed to sustainable growth and
long-term planning
- Dedicated to making investments to
support increased customer demand
- Maintain
efficiency and quality in development and manufacturing processes
Ravensburg, Germany,
October 17, 2023:
Vetter, a leading global Contract Development and Manufacturing
Organization (CDMO), announces additional investments as part of its long-term
dedication to customer partnerships. Vetter’s extensive 40+ years of experience
in aseptic filling and packaging shows a consistent desire for sustainable
growth and corporate development. The pharmaceutical service provider plans
with future-driven considerations to meet its long-lead goals for continued expansion
and customer satisfaction.
Vetter is investing 230 million euros in its new production
building, which is currently under construction at the global corporate headquarters
site in Ravensburg, Germany. The company recently reached a significant milestone
in the construction process, as the shell of the building is now complete,
following the start of construction in November 2021. The building is 122m
long, 44m wide and 32m tall and will feature several new commercial filling
lines to effectively increase aseptic manufacturing capacity for its global customer
base. Vetter plans to install the first cleanrooms by the end of 2024.
According to Vetter Managing Director Thomas Otto, “Our new
production building signifies our ongoing dedication to support the needs of
our customers concerning their complex injectable drug products with regards to
packaging systems, specific process requirements and batch sizes. This is just
one of several investments we are currently undertaking to manage our
sustainable growth.”
Further investments include the increase of lab space for
analytical services, the expansion of filling capacity through new commercial
production lines at other sites in the EU, the expansion in cool storage and
warehousing, as well as a new technical equipment warehouse. Added to this are
the optimization of infrastructure at all global sites to further develop
processes, the development of new compounding and preparation rooms, and as a
result, the optimization of the handling incoming and outgoing products.
“In our industry, the needs of our customers and the
patients they serve continue to evolve,” emphasizes Vetter Managing Director Peter
Soelkner. “Our job as a leading CDMO is to act as a strong partner, take the
proactive steps necessary to identify relevant industry trends, and thus, to
meet the evolving demands of the market through offering adequate resources.
Over the coming years, we will continue to make further investments to stay on
track with this commitment that we have made as a service provider, from the
early development phase to aseptic fill and finish through assembly and
packaging services.”
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance